The clinical practice regarding feeding tube use in patients undergoing radiotherapy for head and neck cancer varies greatly. Ongoing research advances, as well as indications for feeding tube use in contemporary practices are required to provide optimal care.

The 2024 ASTRO Advocacy Update provides participants with an opportunity to better understand how ASTRO advocates for policies that benefit radiation oncology on Capitol Hill.

Navigating medical insurance for radiation treatment in the United States is frustrating and complex, often resulting in disappointment for patients, delays in care, and denials of standard of care treatment.

Despite the rapid advancements, there exists a gap in the integration of radiopharmaceutical therapy within radiation oncology practices.

Radiotherapy plays an important role as a consolidation treatment after systemic therapy, either to shorten the course of systemic therapy and reduce hematological, cardiac and fertility toxicity or to reduce the risk of relapse e.g., for bulky masses.